Blogs about: Ion Channel
Featured Blog
Evotec/Pfizer initiate Phase I trial of VR1 antagonist
Evotec AG have announced the initiation of a Phase I clinical trial of a small molecule VR1 (vanilloid receptor 1) antagonist in collaboration with Pfizer… more →
Ion channel News
ASIC1a and the fear of drowning
dendrite wrote 1 week ago: Image by Sbrimbillina via Flickr Here’s a gene whose relationship to mental function is very s … more →
Enlarged prostate surgery
capros wrote 1 year ago: Should I Get Surgery for My Enlarged Prostate? The key factor in determining whether you should have … more →
Evotec/Pfizer initiate Phase I trial of VR1 antagonist
crimsoncanary wrote 1 year ago: Evotec AG have announced the initiation of a Phase I clinical trial of a small molecule VR1 (vanillo … more →
Inspire modifies denufosol Phase III trial for Cystic Fibrosis
crimsoncanary wrote 1 year ago: Inspire Pharmaceuticals have announced modifications to the clinical protocol for TIGER-2, the Compa … more →
Anesiva insitate Phase II trual of Adlea in Arthroscopic Shoulder Surgery
crimsoncanary wrote 1 year ago: Anesiva have begun a Phase II clinical trial of Adlea, the company’s long-acting capsaicin product i … more →
NeurogesX Initiate Phase I of NGX-1998 Capsaicin Liquid Formulation
crimsoncanary wrote 1 year ago: NeurogesX has initiated a Phase 1 clinical trial of NGX-1998, a high-concentration, capsaicin-based … more →
Vertexs VX-770 improves lung function in cystic fibrosis
crimsoncanary wrote 1 year ago: Data presentes at the 31st European Cystic Fibrosis Society Meeting shows Vertex’s VX-770 to i … more →
AstraZeneca and Cellectricon collaborate on Dynaflow High Throughput Ion Channel Screening
crimsoncanary wrote 1 year ago: AstraZeneca have expanded their collaboration with Cellectricon. AstraZeneca will install two Dynafl … more →
Inspire’s Denufosol shows efficacy in Phase III trials in Cystic Fibrosis
crimsoncanary wrote 1 year ago: Inspire’s denufosol inhalation solution has shown efficacy in Phase III trials in Cystic Fibrosis. F … more →
Phase II trials of Adlea in post orthopedic surgery pain to take place in South Korea
crimsoncanary wrote 1 year ago: Anesiva to begin Phase II trial of Capsaicin drug Adlea for use in the treatment of post orthopedic … more →
NeurogesX submit IND for liquid formulation of Capsaicin, NGX-1998
crimsoncanary wrote 1 year ago: NeurogesX have submitted an IND for the liquid formulation of Capsaicin, NGX-1998 for the treatment … more →
US and WO patent update for the week ending 05/23
crimsoncanary wrote 1 year ago: US and WO ion channel patents have been updated for this week at IonChannelCentral.com … more →
TRPV4 Channel Agonist GSK1016790A Induces Urinary Bladder Contraction and Hyperactivity
crimsoncanary wrote 1 year ago: GSK’s transient receptor potential vanilloid 4 (TRPV4) agonist GSK1016790A contracts mouse bla … more →
Dendreons TRPM8 modulator D3263 shows promise in BPH
crimsoncanary wrote 1 year ago: Dendreon’s TRPM8 modulator D-3263 has been shown to reduce prostate weight by 39% in an animal … more →
Amitiza (lubiprostone) relieves IBS in Phase III
crimsoncanary wrote 1 year ago: Chloride channel agonist Amitiza (lubiprostone) had been shown to significantly relieve symptoms of … more →
YM-758 pharmacokinetics in rats and humans
crimsoncanary wrote 1 year ago: The hepatic uptake and excretion of YM-758 is otlined in a Drug Metabolism and Disposition paper. YM … more →
US and WO patent update for the week ending 05/16
crimsoncanary wrote 1 year ago: US and WO ion channel patents have been updated for this week at IonChannelCentral.com … more →
Azor shows efficacy in difficult to treat patient groups
crimsoncanary wrote 1 year ago: Data presented at ASH shows that Azor (amlodipine and olmesartan medoxomil) safely and effectively l … more →
Exforge treatment effective in black patients
crimsoncanary wrote 1 year ago: Black patients treated with Exforge (Amlodipine/Valsartan) have been show to experience a significan … more →
